vs
Business First Bancshares, Inc.（BFST）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Business First Bancshares, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$83.1M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 7.1%），Business First Bancshares, Inc.自由现金流更多（$92.0M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 16.8%）
第一公民银行股份公司是一家银行控股公司，总部位于美国北卡罗来纳州罗利，是美国规模最大的银行机构之一。公司核心子公司第一公民银行在全美23个州经营着超过500家网点，另一子公司硅谷银行则在15个州设有39家办事处。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
BFST vs PBYI — 直观对比
营收规模更大
BFST
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出20.6%
7.1%
自由现金流更多
BFST
多$77.6M
$14.4M
两年增速更快
PBYI
近两年复合增速
16.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $83.1M | $75.5M |
| 净利润 | — | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 33.2% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 7.1% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.71 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BFSTPBYI
| Q4 25 | $83.1M | $75.5M | ||
| Q3 25 | $80.9M | $54.5M | ||
| Q2 25 | $81.5M | $52.4M | ||
| Q1 25 | $79.2M | $46.0M | ||
| Q4 24 | $77.6M | $59.1M | ||
| Q3 24 | $66.9M | $80.5M | ||
| Q2 24 | $66.2M | $47.1M | ||
| Q1 24 | $60.9M | $43.8M |
净利润BFSTPBYI
| Q4 25 | — | — | ||
| Q3 25 | $22.9M | $8.8M | ||
| Q2 25 | $22.1M | $5.9M | ||
| Q1 25 | $20.5M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $17.8M | $20.3M | ||
| Q2 24 | $17.2M | $-4.5M | ||
| Q1 24 | $13.6M | $-4.8M |
毛利率BFSTPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率BFSTPBYI
| Q4 25 | 33.2% | 22.7% | ||
| Q3 25 | 35.7% | 17.6% | ||
| Q2 25 | 34.4% | 12.7% | ||
| Q1 25 | 32.6% | 8.7% | ||
| Q4 24 | 27.5% | 22.6% | ||
| Q3 24 | 34.0% | 27.4% | ||
| Q2 24 | 32.9% | -4.6% | ||
| Q1 24 | 28.2% | -5.3% |
净利率BFSTPBYI
| Q4 25 | — | — | ||
| Q3 25 | 28.2% | 16.2% | ||
| Q2 25 | 27.1% | 11.2% | ||
| Q1 25 | 25.9% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 26.7% | 25.2% | ||
| Q2 24 | 26.0% | -9.6% | ||
| Q1 24 | 22.3% | -11.0% |
每股收益（稀释后）BFSTPBYI
| Q4 25 | $0.71 | $0.26 | ||
| Q3 25 | $0.73 | $0.17 | ||
| Q2 25 | $0.70 | $0.12 | ||
| Q1 25 | $0.65 | $0.06 | ||
| Q4 24 | $0.51 | $0.40 | ||
| Q3 24 | $0.65 | $0.41 | ||
| Q2 24 | $0.62 | $-0.09 | ||
| Q1 24 | $0.48 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $411.2M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $896.9M | $130.3M |
| 总资产 | $8.2B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资BFSTPBYI
| Q4 25 | $411.2M | $97.5M | ||
| Q3 25 | $399.1M | $94.4M | ||
| Q2 25 | $495.8M | $96.0M | ||
| Q1 25 | $312.9M | $93.2M | ||
| Q4 24 | $319.1M | $101.0M | ||
| Q3 24 | $213.2M | $96.7M | ||
| Q2 24 | $208.1M | $96.8M | ||
| Q1 24 | $185.9M | $107.2M |
总债务BFSTPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益BFSTPBYI
| Q4 25 | $896.9M | $130.3M | ||
| Q3 25 | $878.4M | $115.3M | ||
| Q2 25 | $848.4M | $104.7M | ||
| Q1 25 | $826.3M | $97.1M | ||
| Q4 24 | $799.5M | $92.1M | ||
| Q3 24 | $699.5M | $71.1M | ||
| Q2 24 | $664.5M | $48.5M | ||
| Q1 24 | $649.0M | $51.0M |
总资产BFSTPBYI
| Q4 25 | $8.2B | $216.3M | ||
| Q3 25 | $8.0B | $202.9M | ||
| Q2 25 | $7.9B | $194.9M | ||
| Q1 25 | $7.8B | $196.2M | ||
| Q4 24 | $7.9B | $213.3M | ||
| Q3 24 | $6.9B | $220.7M | ||
| Q2 24 | $6.7B | $205.0M | ||
| Q1 24 | $6.7B | $214.1M |
负债/权益比BFSTPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $92.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $92.0M | $14.4M |
| 自由现金流率自由现金流/营收 | 110.7% | 19.1% |
| 资本支出强度资本支出/营收 | 0.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $165.6M | $41.7M |
8季度趋势，按日历期对齐
经营现金流BFSTPBYI
| Q4 25 | $92.1M | $14.4M | ||
| Q3 25 | $32.4M | $9.7M | ||
| Q2 25 | $14.0M | $14.1M | ||
| Q1 25 | $28.7M | $3.6M | ||
| Q4 24 | $61.4M | $15.6M | ||
| Q3 24 | $21.4M | $11.0M | ||
| Q2 24 | $15.1M | $1.0M | ||
| Q1 24 | $7.6M | $11.2M |
自由现金流BFSTPBYI
| Q4 25 | $92.0M | $14.4M | ||
| Q3 25 | $32.1M | $9.7M | ||
| Q2 25 | $13.8M | $14.1M | ||
| Q1 25 | $27.7M | $3.6M | ||
| Q4 24 | $59.8M | $15.6M | ||
| Q3 24 | $21.0M | $11.0M | ||
| Q2 24 | $14.0M | $1.0M | ||
| Q1 24 | $7.2M | — |
自由现金流率BFSTPBYI
| Q4 25 | 110.7% | 19.1% | ||
| Q3 25 | 39.6% | 17.7% | ||
| Q2 25 | 16.9% | 26.8% | ||
| Q1 25 | 34.9% | 7.7% | ||
| Q4 24 | 77.1% | 26.4% | ||
| Q3 24 | 31.4% | 13.7% | ||
| Q2 24 | 21.2% | 2.1% | ||
| Q1 24 | 11.8% | — |
资本支出强度BFSTPBYI
| Q4 25 | 0.1% | 0.0% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 2.0% | 0.0% | ||
| Q3 24 | 0.6% | 0.0% | ||
| Q2 24 | 1.6% | 0.0% | ||
| Q1 24 | 0.6% | 0.0% |
现金转化率BFSTPBYI
| Q4 25 | — | — | ||
| Q3 25 | 1.42× | 1.10× | ||
| Q2 25 | 0.63× | 2.41× | ||
| Q1 25 | 1.40× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.20× | 0.54× | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
